Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trimegah Bangun Persada Tbk. (NCKL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Trimegah Bangun Persada Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Trimegah Bangun Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp940 (market cap 60.26T, 66.68M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 363× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (66.68M versus 324K). Which is the better fit depends on your goals.

NCKLOBAT
Market Cap
60.26T166.01B
Volume
66.68M324K
Lot
666.76K3.24K
Turnover
62.63B77.68M
Average Price
939.35239.75
Value
62.63B77.68M
Indicative Equilibrium Price
940240
Indicative Equilibrium Volume
13.51K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NCKL
View details
OBAT
View details

About Trimegah Bangun Persada Tbk.

PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.

Read more on NCKL

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT